FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ketamine Injection
Status: Currently in Shortage
»Date first posted: 02/16/2018
»Therapeutic Categories: Anesthesia

Expand all

Hospira, Inc. (Reverified 06/29/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg/5 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2051-05) Next Delivery and Estimated Recovery: 2019 Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter

Other
500 mg/10 mL (50 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2053-10) Next Delivery and Estimated Recovery: 2019 Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter

Other

Mylan Institutional (Reverified 07/03/2018)

Company Contact Information:
800-RXMYLAN (1-800-796- 9526)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg / 20 mL (NDC 67457-181-20) Intermittent supply until Q3 2018. Demand increase for the drug
500 mg / 10 mL (NDC 67457-001-10) Intermittent supply until Q3 2018. Demand increase for the drug
1000 mg / 10 mL (NDC 67457-108-10) Intermittent supply until Q3 2018. Demand increase for the drug

Par Pharmaceutical (Revised 03/30/2018)

Company Contact Information:
201-802-4000

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/mL, 20 mL MDV (NDC 42023-113-10) Releasing limited inventory in April 2018 Demand increase for the drug
100 mg/mL, 5 mL MDV (NDC 42023-115-10) Releasing limited inventory in April 2018 Demand increase for the drug
50 mg/mL, 10 mL MDV (NDC 42023-114-10) Releasing limited inventory in April 2018 Demand increase for the drug

West-Ward Pharmaceuticals (New 04/06/2018)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/mL, 10 mL vial (NDC 0143-9508-10) West-Ward currently has inventory available. Additional lots are scheduled to be manufactured and available in the April - May 2018 timeframe. Product will be made available as it is released. Demand increase for the drug
100 mg/mL, 5 mL vial (NDC 0143-9509-10) West-Ward currently has inventory available. Additional lots are scheduled to be manufactured and available in the April - May 2018 timeframe. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English